KRS Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-330
| Closed | -$209K | – | 110 |
|
|
2025
Q1 | $209K | Hold |
330
| – | – | 0.17% | 100 |
|
|
2024
Q4 | $235K | Hold |
330
| – | – | 0.17% | 103 |
|
|
2024
Q3 | $347K | Hold |
330
| – | – | 0.25% | 75 |
|
|
2024
Q2 | $347K | Hold |
330
| – | – | 0.26% | 81 |
|
|
2024
Q1 | $318K | Hold |
330
| – | – | 0.26% | 88 |
|
|
2023
Q4 | $290K | Hold |
330
| – | – | 0.27% | 88 |
|
|
2023
Q3 | $272K | Sell |
330
-15
| -4% | -$12.3K | 0.29% | 86 |
|
|
2023
Q2 | $248K | Hold |
345
| – | – | 0.25% | 95 |
|
|
2023
Q1 | $283K | Sell |
345
-10
| -3% | -$8.22K | 0.32% | 87 |
|
|
2022
Q4 | $256K | Buy |
355
+40
| +13% | +$28.9K | 0.35% | 89 |
|
|
2022
Q3 | $216K | Buy |
+315
| New | +$216K | 0.3% | 91 |
|
|
2022
Q2 | – | Sell |
-315
| Closed | -$220K | – | 108 |
|
|
2022
Q1 | $220K | Hold |
315
| – | – | 0.24% | 108 |
|
|
2021
Q4 | $198K | Buy |
+315
| New | +$198K | 0.17% | 118 |
|